Back

PRIME Education, Inc. (PRIME®)

  • Breast Neoplasms
  • Genetic Testing

Mastering Genetic Testing and Elevating Care for Patients With BRCA-Mutated Breast Cancer

Identifying patients with germline BRCA-mutated breast cancer early relies on timely genetic testing, but many eligible patients are still not receiving testing. Systemic barriers and a shortage of trained genetic counselors in some settings has shifted much of the responsibility for patient education, pre- and post-test counseling, and intricate testing decisions to oncology care teams.Join us for a dynamic discussion featuring an expert breast cancer oncologist on practical strategies, workflow enhancements, and process improvements to optimize genetic testing to identify patients with BRCA-mutated breast cancer. In this session, you will have the opportunity to:Review action plans to address obstacles related to genetic testingDiscuss strategies for overcoming barriers to integrating guideline-concordant genetic testing within multidisciplinary clinical workflowsApply best practices for sustained practice improvements in genetic testing. Don’t miss this opportunity to enhance your clinical expertise and gain practical tools to optimize outcomes for your patients with germline BRCA-mutated breast cancer.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
November 23, 2026
End Date
November 25, 2026

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1 credit
  • Commercial Support
  • When
    Nov 23–24, 2026